Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Feb 25 | BMY Bristol-Myers Squibb | Common Stock, $0.10 par value | Payment of exercise | Dispose F | No | No | 58.95 | 3,725 | 219.59 k | 7,133 |
1 Feb 25 | BMY Bristol-Myers Squibb | Common Stock, $0.10 par value | Option exercise | Acquire M | No | No | 0 | 10,078 | 0.00 | 10,858 |
1 Feb 25 | BMY Bristol-Myers Squibb | RSU Common Stock, $0.10 par value | Option exercise | Dispose M | No | No | 0 | 10,078 | 0.00 | 20,158 |
30 May 24 | MURA Mural Oncology | Stock Option Ordinary Shares | Grant | Acquire A | No | No | 3.35 | 8,462 | 28.35 k | 8,462 |
10 Mar 24 | BMY Bristol-Myers Squibb | Performance Shares Common Stock, $0.10 par value | Grant | Acquire A | No | No | 0 | 5,805 | 0.00 | 5,805 |
10 Mar 24 | BMY Bristol-Myers Squibb | Market Share Units Common Stock, $0.10 par value | Grant | Acquire A | No | No | 0 | 3,870 | 0.00 | 3,870 |
1 Mar 24 | BMY Bristol-Myers Squibb | RSU Common Stock, $0.10 par value | Grant | Acquire A | No | No | 0 | 9,858 | 0.00 | 9,858 |